Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.

Anaemia cardiovascular diseases chronic erythrocyte transfusion inflammatory bowel diseases infusions intravenous iron iron-deficiency menorrhagia pregnancy complications renal insufficiency

Journal

Annals of medicine
ISSN: 1365-2060
Titre abrégé: Ann Med
Pays: England
ID NLM: 8906388

Informations de publication

Date de publication:
12 2021
Historique:
entrez: 11 1 2021
pubmed: 12 1 2021
medline: 22 9 2021
Statut: ppublish

Résumé

Iron deficiency is a common cause of morbidity and can arise as a consequence or complication from many diseases. The use of intravenous iron has increased significantly in the last decade, but concerns remain about indications and administration. Modern intravenous iron preparations can facilitate rapid iron repletion in one or two doses, both for absolute iron deficiency and, in the presence of inflammation, functional iron deficiency, where oral iron therapy is ineffective or has not worked. A multidisciplinary team of experts experienced in iron deficiency undertook a consensus review to support healthcare professionals with practical advice on managing iron deficiency in gastrointestinal, renal and cardiac disease, as well as; pregnancy, heavy menstrual bleeding, and surgery. We explain how intravenous iron may work where oral iron has not. We provide context on how and when intravenous iron should be administered, and informed opinion on potential benefits balanced with potential side-effects. We propose how intravenous iron side-effects can be anticipated in terms of what they may be and when they may occur. The aim of this consensus is to provide a practical basis for educating and preparing staff and patients on when and how iron infusions can be administered safely and efficiently. Key messages Iron deficiency treatment selection is driven by several factors, including the presence of inflammation, the time available for iron replenishment, and the anticipated risk of side-effects or intolerance. Intravenous iron preparations are indicated for the treatment of iron deficiency when oral preparations are ineffective or cannot be used, and therefore have applicability in a wide range of clinical contexts, including chronic inflammatory conditions, perioperative settings, and disorders associated with chronic blood loss. Adverse events occurring with intravenous iron can be anticipated according to when they typically occur, which provides a basis for educating and preparing staff and patients on how iron infusions can be administered safely and efficiently.

Identifiants

pubmed: 33426933
doi: 10.1080/07853890.2020.1867323
pmc: PMC7877947
doi:

Substances chimiques

Iron Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-285

Subventions

Organisme : Department of Health
ID : 10/104/06
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK107309
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD096863
Pays : United States

Références

Am J Obstet Gynecol. 2019 Jul;221(1):19-29.e3
pubmed: 30578747
Int J Gynaecol Obstet. 2011 Apr;113(1):3-13
pubmed: 21345435
Gut. 2011 Oct;60(10):1309-16
pubmed: 21561874
Transfus Apher Sci. 2019 Feb;58(1):50-57
pubmed: 30545659
Eur Heart J. 2015 Mar 14;36(11):657-68
pubmed: 25176939
Lancet. 2020 Dec 12;396(10266):1895-1904
pubmed: 33197395
Med J Aust. 2020 Jul;213(2):85-86
pubmed: 32453445
Blood Transfus. 2019 Mar;17(2):137-145
pubmed: 30418128
J Am Coll Cardiol. 2018 May 15;71(19):2270-2271
pubmed: 29747838
Am Heart J. 2011 May;161(5):822-831.e2
pubmed: 21570510
Blood. 2016 Jun 9;127(23):2809-13
pubmed: 27044621
Blood. 2019 Jan 3;133(1):40-50
pubmed: 30401705
Nephrol Dial Transplant. 2001 Jan;16(1):115-9
pubmed: 11209003
J Am Coll Cardiol. 2018 Feb 20;71(7):782-793
pubmed: 29447741
Am J Med. 2000 Jul;109(1):27-32
pubmed: 10936475
Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):126-31
pubmed: 20303210
J Crohns Colitis. 2015 Mar;9(3):211-22
pubmed: 25518052
Nephrol Dial Transplant. 2014 Nov;29(11):2075-84
pubmed: 24891437
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Blood. 2019 Jan 3;133(1):30-39
pubmed: 30401704
Semin Nephrol. 2016 Mar;36(2):87-93
pubmed: 27236128
Clin Nutr. 2017 Apr;36(2):321-347
pubmed: 28131521
Blood. 2010 Dec 2;116(23):4754-61
pubmed: 20826717
Lancet Haematol. 2020 Apr;7(4):e342-e350
pubmed: 32220343
Haematologica. 2015 May;100(5):e214-5
pubmed: 25944640
Mayo Clin Proc. 2015 Jan;90(1):12-23
pubmed: 25572192
Am J Obstet Gynecol. 1984 Aug 1;149(7):788-93
pubmed: 6380294
Cell. 2017 Jan 26;168(3):344-361
pubmed: 28129536
Br Med Bull. 2019 Sep 19;131(1):119
pubmed: 31220225
Am J Kidney Dis. 1996 Oct;28(4):529-34
pubmed: 8840942
Dermatol Surg. 2020 Sep;46(9):1176-1182
pubmed: 31714385
Eur J Heart Fail. 2016 Jul;18(7):786-95
pubmed: 26821594
Biochim Biophys Acta. 1999 Nov 10;1413(3):99-107
pubmed: 10556622
J Nutr. 2001 Feb;131(2S-2):568S-579S; discussion 580S
pubmed: 11160590
Vox Sang. 2017 Apr;112(3):219-228
pubmed: 28198084
J Perinatol. 2019 Apr;39(4):519-532
pubmed: 30692612
Clin Nutr. 2020 Mar;39(3):737-745
pubmed: 30981629
Aust Prescr. 2020 Oct;43(5):160-163
pubmed: 33093742
Curr Med Res Opin. 2013 Apr;29(4):291-303
pubmed: 23252877
BMC Womens Health. 2020 Jun 12;20(1):123
pubmed: 32532350
Eur J Heart Fail. 2018 Jan;20(1):125-133
pubmed: 28436136
J Bone Miner Res. 2013 Aug;28(8):1793-803
pubmed: 23505057
Haematologica. 2014 Nov;99(11):1671-6
pubmed: 25420283
J Intern Med. 2020 Feb;287(2):153-170
pubmed: 31665543
Lancet. 2007 May 5;369(9572):1502-1504
pubmed: 17482969
N Engl J Med. 2019 Jan 31;380(5):447-458
pubmed: 30365356
Cardiovasc Hematol Disord Drug Targets. 2013 Mar 1;13(1):35-44
pubmed: 23030476
N Engl J Med. 2013 Mar 28;368(13):1210-9
pubmed: 23473338
Pharmaceuticals (Basel). 2018 Aug 27;11(3):
pubmed: 30150598
Nephrology (Carlton). 2017 Dec;22(12):969-976
pubmed: 27699922
Arch Gynecol Obstet. 2017 Dec;296(6):1229-1234
pubmed: 28940095
Int J Gynaecol Obstet. 2018 Dec;143(3):393-408
pubmed: 30198563
Anaesthesia. 2018 Jan;73 Suppl 1:76-84
pubmed: 29313907
Acta Haematol. 2019;142(1):8-12
pubmed: 30970354
JAMA. 2017 May 16;317(19):1958-1966
pubmed: 28510680
Gut. 2019 Dec;68(Suppl 3):s1-s106
pubmed: 31562236
JAMA. 2020 Feb 4;323(5):432-443
pubmed: 32016310
Eur J Heart Fail. 2013 Nov;15(11):1267-76
pubmed: 23787722
Ther Clin Risk Manag. 2020 Apr 08;16:245-259
pubmed: 32308402
Int J Gynaecol Obstet. 2015 Mar;128(3):196-200
pubmed: 25627706
N Engl J Med. 2009 Dec 17;361(25):2436-48
pubmed: 19920054
Immunol Allergy Clin North Am. 2014 Aug;34(3):707-23, x-xi
pubmed: 25017687
Curr Opin Nephrol Hypertens. 2017 Jul;26(4):266-275
pubmed: 28399017
Lancet Glob Health. 2018 May;6(5):e548-e554
pubmed: 29571592
Frontline Gastroenterol. 2014 Jul;5(3):190-196
pubmed: 28839769
J Clin Med. 2020 Nov 06;9(11):
pubmed: 33172157
Acta Obstet Gynecol Scand. 1966;45(3):320-51
pubmed: 5922481
Am J Clin Nutr. 1995 Jul;62(1):117-20
pubmed: 7598053
N Engl J Med. 2015 May 7;372(19):1832-43
pubmed: 25946282
JAMA. 2015 Nov 17;314(19):2062-8
pubmed: 26575062
Eur Heart J. 2010 Aug;31(15):1872-80
pubmed: 20570952
Adv Nutr. 2017 Jan 17;8(1):126-136
pubmed: 28096133
Am J Obstet Gynecol. 2019 Jun;220(6):569.e1-569.e7
pubmed: 30885768
Nephrol Dial Transplant. 2006 Feb;21(2):378-82
pubmed: 16286429
Br J Haematol. 2018 Aug;182(4):481-494
pubmed: 29938779
Vox Sang. 2019 May;114(4):363-373
pubmed: 30937914
Am J Nephrol. 2018;47(2):72-83
pubmed: 29439253
Value Health. 2007 May-Jun;10(3):183-94
pubmed: 17532811
Nephrol Dial Transplant. 2018 Sep 1;33(9):1628-1635
pubmed: 29165637
Semin Hematol. 2015 Oct;52(4):313-20
pubmed: 26404443
Kidney Med. 2020 Mar 27;2(3):341-353
pubmed: 32734254
Allergy. 2017 May;72(5):827-830
pubmed: 27977865
Br J Pharmacol. 2015 Nov;172(21):5025-36
pubmed: 26265306
Haematologica. 2020 May;105(5):1232-1239
pubmed: 31413088

Auteurs

Toby Richards (T)

Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.

Christian Breymann (C)

Obstetric Research-Feto Maternal Haematology Unit, University Hospital Zurich, Zurich, Switzerland.

Matthew J Brookes (MJ)

Gastroenterology Unit, Royal Wolverhampton NHS Trust, Wolverhampton, UK.
Research Institute in Healthcare Science (RIHS), University of Wolverhampton, Wolverhampton, UK.

Stefan Lindgren (S)

Department of Gastroenterology and Hepatology, Lund University, Skåne University Hospital, Malmö, Sweden.

Iain C Macdougall (IC)

Department of Renal Medicine, King's College Hospital, London, UK.

Lawrence P McMahon (LP)

Departments of Renal Medicine and Obstetric Medicine, Eastern Health Clinical School, Monash University, Melbourne, Australia.

Malcolm G Munro (MG)

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Department of Obstetrics and Gynecology, Kaiser-Permanente, Los Angeles Medical Center, Los Angeles, CA, USA.

Elizabeta Nemeth (E)

Center for Iron Disorders, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Giuseppe M C Rosano (GMC)

Department of Medical Sciences, IRCCS San Raffaele, Roma, Italy.

Ingolf Schiefke (I)

Department of Gastroenterology, Hepatology, Diabetology and Endocrinology, Klinikum St. Georg, Leipzig, Germany.

Günter Weiss (G)

Department of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.
Christian Doppler Laboratory for Iron Metabolism and Anemia Research, University of Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH